The Big Opening Day Summary
The mega initial public offering (IPO) of healthcare major Manipal Health Enterprises Limited (operating as Manipal Hospitals) kicked off its public book-building process Today, Wednesday, July 29, 2026.
The ₹9,275.22 crore mainboard issue—which carries a fixed price band of ₹560 to ₹590 per share—saw a measured, cautious response from investors during its first bidding session. By the close of trading on Day 1, the overall issue was subscribed 0.14 times (14%). Early demand was anchored primarily by retail applicants and eligible employees, while institutional bidders largely held back, as is typical for large-scale multi-day offerings.
Quick Highlights: Day 1 Subscription & GMP Snapshot
- Day 1 Overall Subscription: Booked 0.14x (14%) by market close.
- Leading Bidding Category: Employee Quota led early participation at 0.86x.
- Retail Demand: Subscribed 0.24x on Day 1.
- Latest Grey Market Premium (GMP): Hovering between +₹9 and +₹10 per share.
- Estimated Listing Price: Projecting an opening near ₹599 to ₹600 per share (~1.5% to 1.7% listing gain over the ₹590 upper cap).
- Anchor Backstop: Successfully secured ₹4,167 crore from top global and domestic anchor funds on July 28.
Check GMP here
Manipal Hospitals IPO Day 1 Subscription Breakdown (July 29, 2026)
| Investor Category | Day 1 Subscription Multiplier | Bidding Status Highlights |
| Qualified Institutional (QIB – Ex Anchor) | 0.15x | Early institutional bids logged ahead of the final day. |
| Non-Institutional (NII/HNI) | 0.07x | High-net-worth bidders tracking steady lot placements. |
| Retail Individual Investors (RII) | 0.24x | Retail quota seeing standard initial day absorption. |
| Eligible Employee Portion | 0.86x | Nearing full allocation coverage on Day 1. |
| Total Consolidated Issue | 0.14x (14%) | Live Day 1 close across exchange clearing desks. |
Grey Market Pulse & Listing Expectations
The unofficial grey market sentiment surrounding Manipal Hospitals remained subdued on its opening day.
- Current GMP: Tracking at ₹9 to ₹10 per share as of Wednesday afternoon.
- Valuation Impact: Against the upper issue price of ₹590, the grey market signals a modest expected debut around ₹599 to ₹600.
- Why the GMP is Muted: Market participants point to the sheer size of the issue (₹9,275 crore) and an elevated post-issue asking valuation of ~85.4x P/E, which leaves limited buffer for quick speculative day-one listing pops.
Day 1 Analyst Perspective: Should You Apply?
For Short-Term Listing Gain Seekers: Given the soft grey market premium of under 2%, short-term flippers aiming for immediate double-digit listing-day pops should exercise caution or wait for institutional QIB momentum on Days 2 and 3.
For Medium-to-Long-Term Value Investors: The company presents a solid structural bet on India’s healthcare expansion. Out of the ₹8,000 crore fresh capital proceeds, over ₹5,550 crore is directly earmarked to pay down corporate debt, which will lower interest charges and expand net margins over FY27–FY28. Long-term investors can consider subscribing with a multi-year view.
Frequently Asked Questions (FAQ)
1. What was the total Day 1 subscription rate for the Manipal Hospitals IPO?
The IPO was subscribed 0.14 times (14%) overall across all categories by the close of bidding on Wednesday, July 29, 2026.
2. What is the current Grey Market Premium (GMP) for Manipal Hospitals?
The latest grey market premium is tracking near +₹9 to +₹10 per share, suggesting an estimated listing gain of roughly 1.5% to 1.7% over the upper cap of ₹590.
3. When does the bidding window close for this IPO?
The public offer remains open for subscription until Friday, July 31, 2026, at 5:00 PM.
4. What are the key allotment and listing dates?
The basis of share allotment will settle on Monday, August 3, with refunds and Demat share credits processing on August 4, followed by its stock exchange listing on Wednesday, August 5, 2026.
Conclusion
Today, the opening session for Manipal Hospitals confirmed that investors are carefully evaluating large-cap healthcare valuations before committing capital. While Day 1 subscription figures reflect a measured start, institutional participation is expected to pick up significantly over the remaining two days. With a clear roadmap for balance-sheet de-leveraging via debt repayment, Manipal Hospitals remains a key defensive asset play to track as bidding progresses through July 31.
Disclaimer: The views expressed are for informational purposes only and do not constitute financial advice. Investing in stocks and IPOs involves significant risk. forgeup.in is not liable for any financial losses. Always consult a certified investment advisor before making any decisions.